Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.

Insinga RP, Laessig RH, Hoffman GL.

J Pediatr. 2002 Oct;141(4):524-31. Erratum in: J Pediatr. 2003 Jan;142(1):56..

PMID:
12378192
2.

Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.

Venditti LN, Venditti CP, Berry GT, Kaplan PB, Kaye EM, Glick H, Stanley CA.

Pediatrics. 2003 Nov;112(5):1005-15.

PMID:
14595039
3.

Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.

Tran K, Banerjee S, Li H, Noorani HZ, Mensinkai S, Dooley K.

Clin Biochem. 2007 Feb;40(3-4):235-41. Epub 2006 Dec 5.

PMID:
17222812
4.

Economic evaluation of tandem mass spectrometry screening in California.

Feuchtbaum L, Cunningham G.

Pediatrics. 2006 May;117(5 Pt 2):S280-6.

PMID:
16735254
5.

Newborn screening for inborn errors of metabolism: a systematic review.

Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, Littlejohns P, Lord J, Wilcox AH.

Health Technol Assess. 1997;1(11):i-iv, 1-95. Review.

6.

Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.

van der Hilst CS, Derks TG, Reijngoud DJ, Smit GP, TenVergert EM.

J Pediatr. 2007 Aug;151(2):115-20, 120.e1-3.

PMID:
17643759
7.

Comprehensive cost-utility analysis of newborn screening strategies.

Carroll AE, Downs SM.

Pediatrics. 2006 May;117(5 Pt 2):S287-95.

PMID:
16735255
8.

Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.

Autti-Rämö I, Mäkelä M, Sintonen H, Koskinen H, Laajalahti L, Halila R, Kääriäinen H, Lapatto R, Näntö-Salonen K, Pulkki K, Renlund M, Salo M, Tyni T.

Acta Paediatr. 2005 Aug;94(8):1126-36.

PMID:
16188860
9.

Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.

Schoen EJ, Baker JC, Colby CJ, To TT.

Pediatrics. 2002 Oct;110(4):781-6.

PMID:
12359795
10.

Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF.

Pediatrics. 2003 Jun;111(6 Pt 1):1399-406.

PMID:
12777559
11.

Projected cost-effectiveness of statewide universal newborn hearing screening.

Keren R, Helfand M, Homer C, McPhillips H, Lieu TA.

Pediatrics. 2002 Nov;110(5):855-64.

PMID:
12415021
12.

Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.

Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S.

Health Technol Assess. 2004 Mar;8(12):iii, 1-121. Review.

13.

The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.

Frazier DM, Millington DS, McCandless SE, Koeberl DD, Weavil SD, Chaing SH, Muenzer J.

J Inherit Metab Dis. 2006 Feb;29(1):76-85.

PMID:
16601872
14.

Economic evaluation of tandem mass spectrometry newborn screening in Australia.

Norman R, Haas M, Chaplin M, Joy P, Wilcken B.

Pediatrics. 2009 Feb;123(2):451-7. doi: 10.1542/peds.2008-0911.

PMID:
19171609
16.

[Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].

Simonsen H.

Ugeskr Laeger. 2002 Nov 25;164(48):5607-12. Review. Danish.

PMID:
12523003
17.

Projected costs, risks, and benefits of expanded newborn screening for MCADD.

Prosser LA, Kong CY, Rusinak D, Waisbren SL.

Pediatrics. 2010 Feb;125(2):e286-94. doi: 10.1542/peds.2009-0605.

PMID:
20123779
18.

Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.

Clayton PT, Doig M, Ghafari S, Meaney C, Taylor C, Leonard JV, Morris M, Johnson AW.

Arch Dis Child. 1998 Aug;79(2):109-15.

19.

An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.

Thiboonboon K, Leelahavarong P, Wattanasirichaigoon D, Vatanavicharn N, Wasant P, Shotelersuk V, Pangkanon S, Kuptanon C, Chaisomchit S, Teerawattananon Y.

PLoS One. 2015 Aug 10;10(8):e0134782. doi: 10.1371/journal.pone.0134782. eCollection 2015.

20.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

Supplemental Content

Support Center